Kahn, S; Ducruet, T; Johri, M; Arsenault, L; Desjardins, L; Desmarais, S; Boucher, P; Joyal, F; Kassis, J; Lamping, D; +5 more... Miron, M.-, J; Roussin, A; Shrier, I; Solymoss, S; for the Venous Thrombosis Outcomes (VETO), StudyInvestigators; (2003) Resource utilisation and loss of productivity during the 4 months following a diagnosis of deep venous thrombosis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/19381 Full text not available from this repository.

Kahn, S; Kurz, X; Lamping, D; Berard, A; Abenhaim, L; Group, FTVS; (2003) Patients with post-thrombotic syndrome have worse disease severity and quality of life than patients with primary chronic venous disease. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/19382 Full text not available from this repository.

Kahn, S; Lamping, D; Ducruet, T; Arsenault, L; Miron, M; Roussin, A; Desmarais, S; Joyal, F; Kassis, J; Solymoss, S; +1 more... Desjardins, L; (2005) The VEINES-QOL/Sym questionnaire is a valid and reliable measure of quality of life in patients with deep venous thrombosis. [Conference or Workshop Item] https://researchonline.lshtm.ac.uk/id/eprint/11032 Full text not available from this repository.

MacCallum, PK; Cooper, JA; Rumley, A; Lowe, GDO; Meade, TW; (2004) Effect of bezafibrate on plasma homocysteine concentration in men with lower extremity arterial disease [Letter to editor]. Journal of Thrombosis and Haemostasis, 2. pp. 364-365. https://researchonline.lshtm.ac.uk/id/eprint/14958 Full text not available from this repository.